- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02814877
Efficacy and Cost-effectiveness of Hospital Antimicrobial Stewardship Programs (CEFECA)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Context: There is a steady increase of the incidence of multidrug resistant bacteria, including some which have become extremely resistant, causing infections that are more and more difficult to treat with antibiotics thus dramatically impairing patient prognosis.
Several guidelines prompt hospitals to set up antimicrobial stewardship programs, with an antibiotic referrer or a dedicated team as a key component. The aim of the study is to encourage a better use of antibiotics, and to contain the emergence of resistance.
However, such programs, when they exist, cover multiple organisations and interventions to improve antimicrobial prescribing, and involve actors from different specialties. Furthermore, there is little information on how antimicrobial stewardship programs are actually implemented in hospitals and the impact of these programs has been difficult to measure.
Many studies, mainly conducted in England and in the United States, have evaluated interventions to control antibiotic prescription in hospitals. Two meta-analyses conclude that they are efficient but the variety of the interventions and the heterogeneity of the obtained results prevent any conclusions on which practices and strategies should be prioritized when conducting antimicrobial control programs.
The studies conducted so far have been mostly monocentric and have evaluated the impact of the interventions on a relatively short period of time. Finally, they rarely considered the costs and the cost-effectiveness of these programs.
More qualitative approaches have highlighted contextual and cultural factors that influence antibiotic prescribing habits and encourage deliverers to consider these factors when designing an intervention to promote appropriate antibiotic use. These studies have also emphasized that prescribers' adherence to guidelines and interventions is a fundamental factor in the success of any strategy. These aspects have not been explored much in the French national context.
Objective: The main goal is to evaluate the efficacy and the cost-effectiveness of strategies to promote appropriate use of antibiotics in hospitals and to identify the most efficient ones, on a short-term but also long-term scale.
The secondary objectives are 1) to map the different antimicrobial stewardship setups in French hospitals and determine the strategies to be evaluated by the model; 2) to measure prescribers' adherence to the different strategies used to control antibiotic prescription, and 3) to identify potential barriers and facilitators to the implementation of effective stewardship programs.
Methods: The project team will use modelling methods and techniques which combine a decision tree and a Markov model to estimate the impact of the different strategies, while considering the associated costs. To define the different strategies (restrictive, educational or structural strategies) and to measure clinicians' adherence to the strategy implemented in their setting, the project team will conduct a survey in a sample of 30 French hospitals (acute care). During this section, the project team will also collect a certain amount of quantitative data (antibiotic consumption per molecule, mean treatment length for selected infections…). These data will help us refine the model's parameters. To supply the model, other resources will be used : data from the relevant literature, computerized system of medical databases Outcome measurements: Main objective: A comparison of the different strategies based on the incremental cost-effectiveness ratio (ICER), which is defined by the difference in costs between interventions, divided by the difference in their measured impact; secondary objectives: accrue high-value information in the field of antibiotic stewardship, namely physicians' adherence to antibiotic counselling and interventions to control its use, as well as potential barriers and facilitators for the effective implementation of such programs.
Study population: Our study is based on modelling patients' hospitalisations and hospitalisation returns on a hypothetical cohort of patients, over a 10 year period.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Jean Christophe LUCET, PHD
- Phone Number: 33 1 40 25 61 94
- Email: jean-christophe.lucet@aphp.fr
Study Contact Backup
- Name: Anne Perozziello
- Phone Number: 33 1 40 25 61 94
- Email: anne.perozziello@aphp.fr
Study Locations
-
-
-
Paris, France
- Recruiting
- Perozziello
-
Contact:
- anne perozziello
- Email: anne.perozziello@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- French hospitals (acute care) selected
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the efficacy and the cost-effectiveness of strategies to promote appropriate use of antibiotics in hospitals and identify the most efficient ones, on a short-term but also long-term scale.
Time Frame: 12 months
|
A comparison of the different strategies based on the incremental cost-effectiveness ratio (ICER), which is defined by the difference in costs between interventions, divided by the difference in their measured impact
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
to map the different antimicrobial stewardship setups in french hospital
Time Frame: 12 months
|
accrue high-value information in the field of antibiotic stewardship,
|
12 months
|
to measure prescribers' adherence to the different strategies used to control antibiotic description
Time Frame: 12 months
|
namely physicians' adherence to antibiotic counselling and interventions to control its use for the effective implementation of such programs.
|
12 months
|
to identify potential barriers and facilitators to the implementation of effective stewardship programs
Time Frame: 12 months
|
namely physicians' adherence to antibiotic counselling and potential barriers and facilitators for the effective implementation of such programs.
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jean Christophe LUCET, APHP
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHRQ15622
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antimicrobial Resistance
-
Tan Tock Seng HospitalNational University Hospital, Singapore; Khoo Teck Puat Hospital; Changi General...CompletedAntimicrobial ResistanceSingapore
-
Tan Tock Seng HospitalNational Healthcare Group Polyclinics; Temasek PolytechnicCompletedAntimicrobial ResistanceSingapore
-
Chinese University of Hong KongCompletedAntimicrobial ResistanceHong Kong
-
University of California, San FranciscoBill and Melinda Gates Foundation; Ministère de la Santé Publique du Niger; Centre... and other collaboratorsNot yet recruiting
-
Chinese University of Hong KongCompleted
-
University Hospital, LimogesCompleted
-
Basilea PharmaceuticaCompletedDrug Resistance | Antimicrobial Agent | Cephalosporins
-
Imperial College LondonThe Behavioural Insights TeamNot yet recruitingAntimicrobial Resistance | Attitude to Health
-
Human Biome Institute S.A.RecruitingAntimicrobial Drug Resistance | Drug Resistance, BacterialPoland
-
Assistance Publique - Hôpitaux de ParisCompletedKnowledge, Perception and Behaviour of Resistance to Antimicrobial Among HCWFrance
Clinical Trials on promotion of appropriate use of antibiotics in hospital
-
VA Office of Research and DevelopmentRecruiting
-
University Hospital, MontpellierINSERM 1061, " Neuropsychiatry: epidemiological and clinical research", MontpellierActive, not recruiting
-
Italian Resuscitation CouncilUnknownOut-Of-Hospital Cardiac Arrest | In-hospital Cardiac ArrestItaly
-
Cliniche Humanitas GavazzeniCompletedCardiac Pacemaker, Artificial | Implantable Cardioverter-DefibrillatorItaly
-
University of Sao Paulo General HospitalUnknownthe Focus of This Study is to Develop an Application for Postoperative Follow-up of Patients With Prostate Cancer
-
Wroclaw Medical UniversityWroclaw Emergency Medical ServicesRecruiting
-
University of PadovaIstituto Oncologico Veneto IRCCS; Humanitas Hospital, ItalyCompletedEsophageal Neoplasms | Colonic Neoplasms | Stomach NeoplasmItaly
-
University Hospital, GhentCompletedBig Toe ProsthesisBelgium
-
Philip Morris Products S.A.Terminated
-
The Dental Hospital of Zhejiang University School...RecruitingMechanical Failure of Dental Implant NosChina